原发性肾小球疾病患者的心血管事件风险
在加拿大不列颠哥伦比亚省基于病理登记的成人原发性肾小球疾病队列中,中位随访6.8年,212例(11.1%)发生心血管复合结局,10年风险14.7%(95%CI 12.8%-16.8%),发生率高于一般人群(SIR 2.46)。疾病类型、基线eGFR和蛋白尿与心血管风险升高相关,加入这些因素可改善模型拟合与风险区分。
要点
- 原发性肾小球疾病患者心血管事件绝对风险高,约为一般人群的2.5倍。
- 总体发生率24.7/1000人年,各疾病类型为12.2-46.1/1000人年。
- 疾病类型、基线eGFR和蛋白尿与心血管风险升高相关,可改善风险分层。
核心结论
- 原发性肾小球疾病患者心血管疾病绝对风险高,约为一般人群的2.5倍。
- 考虑eGFR、蛋白尿和肾小球疾病类型可能改善这些个体的心血管疾病风险分层。
研究设计与样本
- 观察性队列研究,纳入加拿大不列颠哥伦比亚省 centralized pathology registry 中2000-2012年成人原发性肾小球疾病患者:膜性肾病387例、微小病变226例、IgA肾病759例、局灶节段性肾小球硬化540例。
- 采用亚分布风险模型评估结局风险,以非心血管死亡为竞争事件;基于年龄和性别匹配的一般人群计算标准化发生率(SIR)。
主要发现
- 中位随访6.8年期间,212例患者(11.1%)发生心血管复合结局,10年风险14.7%(95%CI 12.8%-16.8%)。
- 总体发生率为24.7/1000人年,各疾病类型发生率为12.2-46.1/1000人年。
- 总体SIR为2.46(95%CI 2.12-2.82),各疾病类型SIR范围为1.38-3.98,均高于一般人群。
- 疾病类型、基线eGFR和蛋白尿与心血管疾病风险升高相关;加入传统风险因素模型后,模型拟合R²为14.3% vs 12.7%,C统计量为0.81 vs 0.78(差值0.02 [95%CI 0.01-0.04]),连续净重分类改善为0.4(95%CI 0.2-0.6)。
临床怎么用
- 作者认为,考虑eGFR、蛋白尿和肾小球疾病类型可能改善这些个体的心血管疾病风险分层。
局限性
- 结局和合并症的确定使用行政数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Little is known about the risk of cardiovascular disease (CVD) in patients with various primary glomerular diseases. In a population-level cohort of adults with primary glomerular disease, we sought to describe the risk of CVD compared with the general population and the impact of traditional and kidney-related risk factors on CVD risk. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: Adults with membranous nephropathy (n = 387), minimal change disease (n = 226), IgA nephropathy (n = 759), and focal segmental glomerulosclerosis (n = 540) from a centralized pathology registry in British Columbia, Canada (2000-2012). EXPOSURE: Traditional CVD risk factors (diabetes, age, sex, dyslipidemia, hypertension, smoking, prior CVD) and kidney-related risk factors (type of glomerular disease, estimated glomerular filtration rate [eGFR], proteinuria). OUTCOME: A composite CVD outcome of coronary artery, cerebrovascular, and peripheral vascular events, and death due to myocardial infarction or stroke. ANALYTICAL APPROACH: Subdistribution hazards models to evaluate the outcome risk with non-CVD death treated as a competing event. Standardized incidence rates (SIR) calculated based on the age- and sex-matched general population. RESULTS: During a median 6.8 years of follow-up, 212 patients (11.1%) experienced the CVD outcome (10-year risk, 14.7% [95% CI, 12.8%-16.8%]). The incidence rate was high for the overall cohort (24.7 per 1,000 person-years) and for each disease type (range, 12.2-46.1 per 1,000 person-years), and was higher than that observed in the general population both overall (SIR, 2.46 [95% CI, 2.12-2.82]) and for each disease type (SIR range, 1.38-3.98). Disease type, baseline eGFR, and proteinuria were associated with a higher risk of CVD and, when added to a model with traditional risk factors, led to improvements in model fit (R2 of 14.3% vs 12.7%), risk discrimination (C-statistic of 0.81 vs 0.78; difference, 0.02 [95% CI, 0.01-0.04]), and continuous net reclassification improvement (0.4 [95% CI, 0.2-0.6]). LIMITATIONS: Ascertainment of outcomes and comorbidities using administrative data. CONCLUSIONS: Patients with primary glomerular disease have a high absolute risk of CVD that is approximately 2.5 times that of the general population. Consideration of eGFR, proteinuria, and type of glomerular disease may improve risk stratification of CVD risk in these individuals. PLAIN-LANGUAGE SUMMARY: Patients with chronic kidney disease are known to be at high risk of cardiovascular disease. Cardiovascular risk in patients with primary glomerular diseases is poorly understood because these conditions are rare and require a kidney biopsy for diagnosis. In this study of 1,912 Canadian patients with biopsy-proven IgA nephropathy, minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy, the rate of cardiovascular events was 2.5 times higher than in the general population and was high for each disease type. Consideration of disease type, kidney function, and proteinuria improved the prediction of cardiovascular events. In summary, our population-level study showed that patients with primary glomerular diseases have a high cardiovascular risk, and that inclusion of kidney-specific risk factors may improve risk stratification.
引用
- Canney M, Gunning HM, Zheng Y, et al. The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases. Am J Kidney Dis. 2022. PMID: 35659570. doi:10.1053/j.ajkd.2022.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。